Download FREE Report Sample
Download Free sampleColorectal cancer diagnostics are a wide range of screening tests and diagnosis procedures that are employed before treating a patient with colon cancer. A typical diagnosis of colorectal cancer consists of tests such as colonoscopy, biopsy, blood sample testing, CT scan,?ultrasound,?MRI?and molecular testing of the growing tumor.?
Colorectal Cancer Diagnostics Market contains market size and forecasts of Colorectal Cancer Diagnostics in Global, including the following market information:
Global Colorectal Cancer Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Colorectal Cancer Diagnostics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
FOB Tests Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Colorectal Cancer Diagnostics include Biocept, Cancer Genetics, Foundation Medicine, Sysmex Corporation, Danaher Corporation, Epigenomics, Illumina, Rosetta Genomics and Exact Science Corporation and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Colorectal Cancer Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Colorectal Cancer Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Colorectal Cancer Diagnostics Market Segment Percentages, by Type, 2021 (%)
FOB Tests
CTC Tests
CEA Tests
Others
Global Colorectal Cancer Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Colorectal Cancer Diagnostics Market Segment Percentages, by Application, 2021 (%)
Hospitals
Specialty Clinics
Others
Global Colorectal Cancer Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Colorectal Cancer Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Colorectal Cancer Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Colorectal Cancer Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biocept
Cancer Genetics
Foundation Medicine
Sysmex Corporation
Danaher Corporation
Epigenomics
Illumina
Rosetta Genomics
Exact Science Corporation
Pathway Genomics Corporation
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
